Dantrolene Related Compound B (50 mg) (5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl) semicarbazone);5-(4-Nitrophenyl)-2-furaldehyde-(2-carboxyMethyl) SeMicarbazone;Dantrolene Related CoMpound B;[(Aminocarbonyl)[[5-(4-nitrophenyl)-2-furanyl]methylene]hydrazino]acetic acid;2-[1-(Aminocarbonyl)-2-[[5-(4-nitrophenyl)-2-furanyl]methylene]hydrazinyl]acetic acid;Dantrolene impurity B;Dantrolene Impurity 2;Dantrolene USP Related Compound B
Dantrolene Related Compound B (50 mg) (5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl) semicarbazone) Chemical Properties
Melting point
>110°C (dec.)
Boiling point
602.0±65.0 °C(Predicted)
density
1.53±0.1 g/cm3(Predicted)
storage temp.
-20°C Freezer, Under inert atmosphere
solubility
DMSO (Slightly), Methanol (Slightly)
pka
4.05±0.10(Predicted)
form
Solid
color
Yellow to Dark Yellow
Safety Information
HS Code
2932190002
MSDS Information
Dantrolene Related Compound B (50 mg) (5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl) semicarbazone) Usage And Synthesis
Uses
5-(4-Nitrophenyl)-2-furaldehyde-(2-carboxymethyl) Semicarbazone is an impurity in the synthesis of Dantrolene (D185000), a muscle relaxant (skeletal). Dantrolene is used in the treatment of malignant hyperthermia.
Dantrolene Related Compound B (50 mg) (5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl) semicarbazone) Preparation Products And Raw materials
